IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE
Journal of Pharmaceutical and Medical Research · 01.06.2026 · 8 (3) · 1-6
DOI: 10.61784/jpmr3078 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pharmaceutical and Medical Research, online erschienen am 01.06.2026. Verfasst von XiuYing Mao und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To explore the clinical value of flash glucose monitoring (FGM) in community-based diabetes management through analysis of a case of nocturnal hypoglycemia identified by FGM.
Methods
A retrospective analysis was conducted on the clinical data of a 74-year-old male patient with type 2 diabetes mellitus. Because of persistently elevated fasting blood glucose levels (7.0-9.0 mmol/L), the patient had been self-adjusting multiple oral hypoglycemic agents over a prolonged period, including acarbose, sitagliptin phosphate, glipizide controlled-release tablets, dapagliflozin, and pioglitazone/metformin. FGM revealed nocturnal hypoglycemia, confirming the presence of the Somogyi phenomenon. Assessment using the Chinese version of the Diabetes Management Self-Efficacy Scale (C-DMSES) indicated low self-efficacy.
Results
Based on the FGM findings, the glucose-lowering regimen was adjusted by discontinuing glipizide controlled-release tablets and pioglitazone/metformin. Individualized dietary and exercise prescriptions, smoking cessation counseling, and psychological support were also provided. After intervention, the antidiabetic regimen was simplified, and no hypoglycemic events were detected on follow-up FGM. At 3 months, fasting blood glucose was 6.8 mmol/L, 2-hour postprandial blood glucose was 9.4 mmol/L, and glycated hemoglobin (HbA1c) was 6.9%. In addition, the C-DMSES score improved significantly.
Conclusion
FGM can effectively identify unrecognized nocturnal hypoglycemia in community-dwelling patients with diabetes and provide an objective basis for individualized and precise comprehensive management. For patients receiving multiple glucose-lowering agents and demonstrating low self-efficacy, FGM combined with a general practitioner-specialist collaborative care model may facilitate safe achievement of glycemic targets.
Zitieren
APA
Mao, X., Shen, L., Wang, N., Zhang, H., Yu, H., Zhang, L., Wang, N., Jin, H., & Yue, J. (2026). IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Pharmaceutical and Medical Research, 8(3), 1-6. https://doi.org/10.61784/jpmr3078
Vancouver
Mao X, Shen L, Wang N, Zhang H, Yu H, Zhang L, et al. IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Pharmaceutical and Medical Research. 2026;8(3):1-6. doi:10.61784/jpmr3078
BibTeX
@article{Mao2026,
author = {Mao, XiuYing and Shen, Lan and Wang, NaNa and Zhang, HaiYing and Yu, Hua and Zhang, Ling and Wang, Ning and Jin, HuiHua and Yue, Jiang},
title = {IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE},
journal = {Journal of Pharmaceutical and Medical Research},
year = {2026},
volume = {8},
number = {3},
pages = {1--6},
doi = {10.61784/jpmr3078}
}
EUVIMED